Biotechnology company Triplet Therapeutics announced that it launched earlier this week with $59 million in financing as it develops ways to treat certain types of genetic disorders at their source. The $59 million includes a $49 million Series A financing round led by MPM Capital and Pfizer Ventures U.S. Co-founder Atlas Venture seeded Triplet with…
Using Experimental Models, Researchers Hope to Target Down Syndrome Gene
Nanotechnology Treatment Shows Promise Against Multiple Sclerosis
Diabetes Drug Alleviates Anxiety in Mice
Stopping Parkinson’s Disease Before it Starts
An Osaka University-led research team has recently published findings that provide a ray of hope for the millions of Parkinson’s disease (PD) sufferers worldwide. Although more common in those aged over sixty, PD can strike at any age, with an estimated prevalence of 41 per 100,000 people in their forties. And while not fatal in…
Synthetic Version of CBD Treats Seizures in Rats
Coat of Proteins Makes Viruses More Infectious, Links Them to Alzheimer’s
New research from Stockholm University and Karolinska Institutet shows that viruses interact with proteins in the biological fluids of their host which results in a layer of proteins on the viral surface. This coat of proteins makes the virus more infectious and facilitates the formation of plaques characteristic of neurodegenerative diseases such as Alzheimer’s disease.…
How a Zebrafish Could Help Solve the Mysteries of Genetic Brain Disease
Multiple Brain Regions Moderate and Link Depressive Mood and Pain
Ragweed Compounds Could Protect Nerve Cells From Alzheimer’s
New Treatment for Stroke in Mice Reduces Brain Damage, Promotes Motor Recovery
Stem Cells Provide Information About Neuron Resilience in ALS
Huntington Drug Successfully Lowers Levels of Disease-causing Protein
Brain Injury From Low Oxygen Affects Specific Cells
Do ‘Microglia’ Hold the Key to Stop Alzheimer’s Disease?
Study Paves Way for Innovative Treatment of Epilepsy
Protein Manipulation Could Be Key to Treating ALS, Frontotemporal Dementia
Researchers Reveal Novel Therapeutic Strategy for ALS
When Neurons are Out of Shape, Antidepressants May Not Work
Experiments with Roundworms Suggest Alternatives for the Treatment of Schizophrenia
Scientists Hunt Down the Brain Circuit Responsible for Alcohol Cravings
Alzheimer’s Treatment Holds Promise for Primary Progressive Aphasia Patients
Neurodegenerative Diseases Identified Using Artificial Intelligence
Insomnia-associated Gene Regions Suggest Underlying Mechanisms, Treatment Targets
ADHD Drug Ritalin Has No Effect on Primate Prefrontal Cortex
In contrast to studies of mice and rats, new research published in eNeuro investigating the effect of methylphenidate (Ritalin) on neuronal activity in monkeys has found no effect of the drug on the prefrontal cortex. The study leaves open the question of how and why Ritalin improves attention in humans. Julio Martinez-Trujillo and colleagues refute their hypothesis…